A major advance in cancer investigation is arising with the use of VHH fragments to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in several kinds of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research